Applicability of a structure-based modelling approach as a tool for in silico screening of oligonucleotides for targeted RNA editing presented at Oligonucleotide Therapeutics Society (OTS) 2018 by Julien Boudet
Find all relevant presentations and publications for each of our programs. From review papers to preclinical posters and clinical data presentations at medical conferences.
ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.
At ProQR, our mission is to edit RNA, treat disease and change lives. This guides every decision we make as we work to develop new treatment options for people living with high unmet need.
Our vision is to create a world where genetics informs your health - but never limit it. By harnessing the power of RNA editing, we strive to make our vision for the future a reality.
